Clinical trial NCT05787847: Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program
Official title: Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Stimulant Use
Lead sponsor: University of Vermont
Sponsor class: OTHER
First posted: 2023-03-28
Enrollment: 27
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The goal of this randomized control pilot study is to learn about a financial incentives intervention among individuals who use stimulants and take part in a community-based syringe exchange program. The main question it aims to answer is how financial incentives for not using stimulants will impact stimulant use. Participants in the experimental group will have the opportunity to earn financial incentives for providing a negative urine sample for stimulants using a point-of-care test, which indicates abstinence from stimulant use, along with health education on the health risks of stimulant use and substance injection. Researchers will compare the experimental group to the control group who will receive health education on the health risks of stimulants use and injection.

Detailed description: The investigators are proposing a two condition, parallel groups, randomized control pilot study to evaluate the efficacy of a financial incentives intervention among individuals who use stimulants and take part in a community-based syringe exchange program. The study design will include recruiting service recipients who already participate in programs offered by a syringe exchange program.The experimental group will have the opportunity to earn financial incentives contingent on providing a negative urine sample for stimulants using a point-of-care test, which indicates abstinence from stimulant use, in addition to health education on the health risks of stimulant use and substance injection. The control group will receive health education on the health risks of stimulants use and injection. All participants will participate in their syringe exchange services as usual. The investigators chose the health education as the control because participants across both conditions already receive the services provided by the syringe exchange program. Moreover, this control condition will help control for a potential type of between-groups variability.

Eligibility criteria: Inclusion Criteria:

* be 18 years or older
* report using stimulants in the past 30 days
* meet the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnosis for stimulant use disorder at a moderate or severe level (i.e., 6 or more of the 11 criteria)
* participation in services at syringe exchange program

Exclusion Criteria:

* failure to meet one or more inclusionary criteria
* individuals who are cognitively impaired by their drug use or psychiatric conditions that could preclude informed consent

Primary outcomes:
measure: stimulant free urine sample
timeFrame: 12 weeks
Secondary outcomes:
Other outcomes:
Locations:
city: Burlington
country: United States
facility: Howard Center
state: Vermont
Study officials:
References: